合計 50 件の最近のインサイダー取引記録が記録されています Vaccitech plc (VACC), 内訳は 37 件の買い および 12 件の売り. インサイダー買い総額は $17.41M インサイダー売り総額は $338.75K.
最近活動のある主要インサイダーには Enright William, Griffiths Graham, Brown Gemma. インサイダー取引記録は、経営陣が株式の評価と将来の見通しをどう見ているかについての洞察を提供します.
インサイダー取引記録 — VACC
| 日付 |
氏名 |
役職 |
取引種別 |
株数 |
平均価格 |
価値 |
保有株数 |
| 2024-01-02 |
Enright William |
Chief Executive Officer |
RSU 付与（制限付株式） |
443,981 |
$3.70 |
$1.64M |
443,981 |
| 2024-01-02 |
Griffiths Graham |
Chief Business Officer |
RSU 付与（制限付株式） |
96,500 |
$3.70 |
$357.05K |
96,500 |
| 2024-01-02 |
Brown Gemma |
Chief Financial Officer |
RSU 付与（制限付株式） |
193,000 |
$3.70 |
$714.1K |
193,000 |
| 2024-01-02 |
Pelletier Nadege |
Chief Scientific Officer |
RSU 付与（制限付株式） |
105,000 |
$3.70 |
$388.5K |
105,000 |
| 2023-06-26 |
Scheeren Joseph |
Director |
情報に基づく買い |
10,000 |
$2.44 |
$24.4K |
23,000 |
| 2023-05-25 |
Wright Robin |
Director |
情報に基づく買い |
13,750 |
$2.66 |
$36.61K |
48,256 |
| 2023-05-11 |
Dawes Karen A |
Director |
RSU 付与（制限付株式） |
19,197 |
$2.27 |
$43.58K |
19,197 |
| 2023-05-11 |
Phillips Anne M. |
Director |
RSU 付与（制限付株式） |
19,197 |
$2.27 |
$43.58K |
19,197 |
| 2023-05-11 |
Hammacher Alex |
Director |
RSU 付与（制限付株式） |
19,197 |
$2.27 |
$43.58K |
19,197 |
| 2023-05-11 |
Morgon Pierre A. |
Director |
RSU 付与（制限付株式） |
19,197 |
$2.27 |
$43.58K |
19,197 |
| 2023-05-11 |
Wright Robin |
Director |
RSU 付与（制限付株式） |
19,197 |
$2.27 |
$43.58K |
19,197 |
| 2023-05-11 |
Scheeren Joseph |
Director |
RSU 付与（制限付株式） |
19,197 |
$2.27 |
$43.58K |
19,197 |
| 2023-03-27 |
Enright William |
Chief Executive Officer |
情報に基づく売り |
15,000 |
$2.42 |
$36.3K |
728,454 |
| 2023-02-01 |
Pelletier Nadege |
Chief Scientific Officer |
RSU 付与（制限付株式） |
485,000 |
$2.90 |
$1.41M |
485,000 |
| 2023-01-30 |
Pelletier Nadege |
Officer |
不明 |
- |
- |
- |
- |
| 2023-01-03 |
Enright William |
Chief Executive Officer |
RSU 付与（制限付株式） |
440,000 |
$2.40 |
$1.06M |
440,000 |
| 2023-01-03 |
Griffiths Graham |
Chief Business Officer |
RSU 付与（制限付株式） |
105,000 |
$2.40 |
$252K |
105,000 |
| 2023-01-03 |
Ellis Christopher |
Chief Operating Officer |
RSU 付与（制限付株式） |
105,000 |
$2.40 |
$252K |
105,000 |
| 2023-01-03 |
Brown Gemma |
Chief Financial Officer |
RSU 付与（制限付株式） |
33,100 |
$2.40 |
$79.44K |
33,100 |
| 2023-01-03 |
Marshall Margaret |
Chief Medical Officer |
RSU 付与（制限付株式） |
60,000 |
$2.40 |
$144K |
60,000 |
| 2023-01-03 |
Evans Thomas George |
Fmr Chief Scientific Officer |
RSU 付与（制限付株式） |
125,000 |
$2.40 |
$300K |
125,000 |
| 2022-09-30 |
M&g Investment Management Ltd |
Director |
その他（買い） |
4,108,752 |
- |
- |
5,197,349 |
| 2022-09-30 |
M&g Alternatives Investment Management Ltd |
Director |
その他（売り） |
4,108,752 |
- |
- |
- |
| 2022-09-26 |
Brown Gemma |
Chief Financial Officer |
RSU 付与（制限付株式） |
334,000 |
$3.07 |
$1.03M |
334,000 |
| 2022-08-25 |
Griffiths Graham |
Chief Business Officer |
情報に基づく売り |
10,000 |
$7.39 |
$73.87K |
104,209 |
| 2022-08-24 |
Ellis Christopher |
Chief Operating Officer |
情報に基づく売り |
25,000 |
$7.07 |
$176.71K |
75 |
| 2022-08-17 |
Griffiths Graham |
Chief Business Officer |
情報に基づく売り |
500 |
$4.76 |
$2.38K |
114,209 |
| 2022-08-17 |
Ellis Christopher |
Chief Operating Officer |
情報に基づく売り |
2,175 |
$4.84 |
$10.53K |
75 |
| 2022-08-15 |
Griffiths Graham |
Chief Business Officer |
情報に基づく売り |
1,220 |
$4.82 |
$5.88K |
114,709 |
| 2022-08-15 |
Ellis Christopher |
Chief Operating Officer |
情報に基づく売り |
2,200 |
$4.78 |
$10.51K |
75 |
| 2022-08-12 |
Griffiths Graham |
Chief Business Officer |
情報に基づく売り |
5,000 |
$4.50 |
$22.5K |
118,329 |
| 2022-06-28 |
Ellis Christopher |
Chief Operating Officer |
情報に基づく売り |
5 |
$6.00 |
$30.00 |
75 |
| 2022-06-23 |
Griffiths Graham |
Chief Business Officer |
オプション行使（売却） |
1,931 |
- |
- |
- |
| 2022-06-15 |
Dawes Karen A |
Director |
RSU 付与（制限付株式） |
18,604 |
$4.27 |
$79.44K |
18,604 |
| 2022-06-15 |
Phillips Anne M. |
Director |
RSU 付与（制限付株式） |
18,604 |
$4.27 |
$79.44K |
18,604 |
| 2022-06-15 |
Hammacher Alex |
Director |
RSU 付与（制限付株式） |
18,604 |
$4.27 |
$79.44K |
18,604 |
| 2022-06-15 |
Morgon Pierre A. |
Director |
RSU 付与（制限付株式） |
18,604 |
$4.27 |
$79.44K |
18,604 |
| 2022-06-15 |
Wright Robin |
Director |
RSU 付与（制限付株式） |
18,604 |
$4.27 |
$79.44K |
18,604 |
| 2022-06-15 |
Scheeren Joseph |
Director |
RSU 付与（制限付株式） |
18,604 |
$4.27 |
$79.44K |
18,604 |
| 2022-04-01 |
Scheeren Joseph |
Director |
情報に基づく買い |
10,000 |
$5.09 |
$50.9K |
13,000 |
| 2022-03-31 |
Hammacher Alex |
Director |
情報に基づく買い |
2,000 |
$5.14 |
$10.28K |
3,000 |
| 2022-01-03 |
Enright William |
Chief Executive Officer |
RSU 付与（制限付株式） |
359,605 |
$11.12 |
$4M |
359,605 |
| 2022-01-03 |
Egorov Georgy |
Chief Financial Officer |
RSU 付与（制限付株式） |
114,000 |
$11.12 |
$1.27M |
114,000 |
| 2022-01-03 |
Griffiths Graham |
Chief Business Officer |
RSU 付与（制限付株式） |
80,000 |
$11.12 |
$889.6K |
80,000 |
| 2022-01-03 |
Marshall Margaret |
Chief Medical Officer |
RSU 付与（制限付株式） |
80,000 |
$11.12 |
$889.6K |
80,000 |
| 2022-01-03 |
Ellis Christopher |
Chief Operating Officer |
RSU 付与（制限付株式） |
80,000 |
$11.12 |
$889.6K |
80,000 |
| 2022-01-03 |
Evans Thomas George |
Chief Scientific Officer |
RSU 付与（制限付株式） |
80,000 |
$11.12 |
$889.6K |
80,000 |
| 2021-12-31 |
Hammacher Alex |
Director |
情報に基づく買い |
1,000 |
$10.86 |
$10.86K |
1,000 |
| 2021-12-22 |
Wright Robin |
Director |
情報に基づく買い |
10,000 |
$9.97 |
$99.7K |
34,506 |
| 2021-12-17 |
Griffiths Graham |
Chief Business Officer |
オプション行使（売却） |
102,279 |
$0.00 |
$40.91 |
- |
■ 情報付き — 公開市場取引（最も重要）
■ 情報なし（買い） — 報酬・オプション行使・転換
■ 情報なし（売り） — 源泉徴収・付与売却
■ 中立 — 贈与・信託・失効
